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A Socratic Dialogue 
 
Vance Berger 
National Institute of Health 
 
 
Socrates has found some aspects of medical biostatistics a bit confusing, and wishes to discuss some of 
these issues with Simplicio, a prominent medical researcher.  This Socratic dialogue will shed some light 
on the errant use of parametric analyses in clinical trials. 
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Introduction 
 
Socrates: Good morning Simplicio, how are you 
today? 
 
Simplicio: Doing well, thank you, and how are 
you Socrates? 
 
Socrates: Not bad, thank you, but a bit confused 
by some of these newfangled ideas I am now 
seeing in the medical literature. Tell me, 
Simplicio, is it not the case that you also 
contribute to this medical literature?  If so, then 
you must be somewhat of an expert, and 
certainly in a position to teach me some of the 
analyses so that I will no longer be confused. 
 
Simplicio: Yes, Socrates, in fact I was part of a 
research team that recently published a clinical 
trial is a prestigious medical journal.  Would you 
like a reprint? 
 
Socrates: No thank you, I have already read it. 
And it contributed to my confusion. 
 
Simplicio: How so, Socrates?  
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Socrates: In many ways, but let us focus, at least 
for now, on just one of these ways. You mention 
that you will compare the blood pressures 
between the treatment groups by using a t-test, is 
that right? 
 
Simplicio: Yes, although I fear that, being a 
laymen, you are not using sufficiently precise 
language. The primary endpoint in our cardiac 
trial was the diastolic blood pressure 12 weeks 
after treatment. It is this endpoint that we 
compared with a t-test. 
 
Socrates: That is all very well, but my interest at 
the moment is in the t-test itself, and not in the 
specific details of the variable on which it was 
used. I thought that I had read somewhere that 
the t-test requires normality to be valid, is this 
not so? And I also read about permutation tests 
that do not require normality for their validity. 
 
Simplicio: Technically, yes, but in practice the 
distributions are close enough to Gaussian that 
we can treat them as such. And we do not use 
permutation tests for a variety of reasons. 
 
Socrates: Pray tell me these reasons, dear 
Simplicio. 
 
Simplicio: For one thing, permutation tests use 
an overly restrictive null hypothesis, specifically 
that the entire distribution of outcomes is the 
same across treatment groups. In contrast, the t-
test is testing only the equality of the means. 
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Socrates: So the permutation test would be 
sensitive to changes in spread and/or shape, 
whereas the t-test would not? 
 
Simplicio: Yes, I believe this to be true. 
 
Socrates: But I also read that the t-test requires 
equal variances, or homogeneity, to be valid. 
Does this mean that without equal variances it is 
not valid, or might have a high probability of 
rejecting a true null hypothesis? 
 
Simplicio: We compute the p-value under the 
assumption that the null hypothesis is true, so 
this would specify that the variances are equal. 
 
Socrates: So the null hypothesis is that the 
means are the same and that the variances are 
the same, across the two treatment groups? 
 
Simplicio: Quite so. 
 
Socrates: Did you not tell me that the benefit of 
the t-test was the ability to test nothing more 
than the equality of the means? 
 
Simplicio: I need to confer with my text book, 
but remember, that was only one reason. We 
also use the t-test because it is robust to 
violations of its assumptions. 
 
Socrates: Robustness sounds nice. What does it 
actually mean? If the data are not normally 
distributed, and/or the variances are not equal, 
then the t-test p-value is the same as it would 
have been had the data been normally distributed 
and the variances equal? 
 
Simplicio: Yes, I believe so. 
 
Socrates: If the variances are unequal, then we 
can make them equal by increasing the smaller 
to match the larger, by decreasing the larger to 
match the smaller, by bringing them both in to 
the mean (or geometric mean or harmonic 
mean), or in any other of a myriad number of 
ways. The t-test p-value is the same as which 
one of these?  Or are they all the same? 
 
Simplicio: Yes, I would say that they will all be 
the same. 
Socrates: Is it not the case that with larger 
variances the p-value will be larger, and with 
smaller variances the p-value will be smaller? 
 
Simplicio: Yes, I am afraid so. 
 
Socrates: So then would you agree that the t-test 
p-value cannot possibly agree with all possible 
values of the t-test p-value when the variances 
across groups are equal? 
 
Simplicio: Yes, I am afraid so. 
 
Socrates: Once again, what does this supposed 
robustness mean? 
 
Simplicio: I was mistaken, but now I remember. 
Robustness means that even if the assumptions 
are violated, the t-test p-value will still be close 
to the exact one. 
 
Socrates: Is there but one exact p-value to be 
close to? 
 
Simplicio: There is only one way to conduct an 
exact permutation test when using the same 
randomization scheme as was used in the study 
and the t-test statistic. 
 
Socrates: I will agree that this is a well-defined 
p-value, this exact t-test p-value. So your 
statement is beginning to take some form, but 
there is still ambiguity in the closeness concept. 
Can we say that the difference in p-values is 
bounded by some function of the extent to which 
the assumptions underlying the t-test are 
violated? 
For example, if R is the ratio of 
variances across the two groups, and D is the 
difference between the t-test p-value and the 
exact t-test p-value, then can we say something 
to the effect that |D|<log(R)? I should be quite 
interested in any theorem of this sort, especially 
if it accounts for and quantifies deviations from 
both normality and homoscedasticity. 
 
Simplicio: I am not aware of any such theorems, 
but in practice the two p-values are usually 
close. That is, D is usually quite small. 
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Socrates: Do you have the values of D from 
prior studies to substantiate this assertion? 
 
Simplicio: No. 
 
Socrates: Do you even bother to compute the 
exact p-value? 
 
Simplicio: We do if the assumptions are grossly 
violated. 
 
Socrates: You mean if the assumptions are 
violated enough that D would be large? 
 
Simplicio: Yes. 
 
Socrates: Yet you never actually compute D? 
 
Simplicio: Correct. 
 
Socrates: So you presume to know when D is 
large or small based on a cursory examination of 
the extent to which the assumptions are violated, 
then take the smallness of D in these cases as a 
known fact with which to justify continuing in 
this fashion? Is this not circular reasoning? 
 
Simplicio: Perhaps so, but we use the exact test 
when we need to. 
 
Socrates: You said you do this when the 
assumptions are violated enough that D would 
be expected to be large. Why not use the t-test 
even in these cases? 
 
Simplicio: Socrates, you are not seriously 
suggesting that we use the t-test when its 
assumptions are known to be grossly violated? 
Especially after grilling me for using it when the 
assumptions are violated to a lesser degree? 
 
Socrates: My good man, I am not suggesting 
anything. Recall that you are the clinical trials 
expert, and I am merely trying to learn from you.  
Right now I want to learn why you do not use 
the t-test when the assumptions are badly 
violated. 
 
Simplicio: I am afraid that this is a trap, and you 
are asking me an obvious question just to see 
what I will say, but the reason is that we do not 
want to use the t-test if its assumptions are badly 
violated because then it may give distorted 
results. 
 
Socrates: When you say “distorted” you are 
referring implicitly to deviation from some gold 
standard, presumably the exact test? 
 
Simplicio: Yes, that is correct. 
 
Socrates: Is it the exact p-value, and not the t-
test p-value, that is of interest? It was 
conceivable that the t-test itself was the quantity 
of interest, but now it appears that this is not the 
case, and that when you use the t-test, you do so 
only so that it can serve as an approximation to 
the exact p-value? 
 
Simplicio: Quite right Socrates. 
 
Socrates: I understand the need for 
approximations in some cases. For example, one 
could compute the number of defective items in 
a large batch by examining each one, but this 
would consume large amounts of resources, so a 
sample is taken and an estimate based on this 
sample is offered as an approximation so as to 
save time and money. 
 
Simplicio: Yes, that is a good example. 
 
Socrates: Similarly, when you want to compute 
the area under the curve of some function that is 
not written explicitly in closed form, you could 
graph the function on your computer screen, 
trace the region below it with a marker, get a 
glass cutter, cut out the glass from the screen to 
correspond to this area, then weigh the glass. 
But instead you rely on an approximation so as 
to save the computer screen, is that correct? 
 
Simplicio: Yes, I suppose so. 
 
Socrates: Do you see the common element in 
these two examples? 
 
Simplicio: Yes, in both cases we needed to use 
an approximation. 
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Socrates: No Simplicio, we did not need to use 
an approximation, but we chose to do so in order 
to save resources. 
 
Simplicio: Yes, that was what I meant. 
 
Socrates: When you use the t-test as an 
approximation, what resources are you saving? 
 
Simplicio: What do you mean? 
Socrates: What great cost is involved in 
computing the exact test p-value? Clearly, you 
can compute it, since you just told me that you 
would compute it if the situation so warranted.  I 
am trying now to get some sense of the cost-
benefit ratio in doing so. Do you need to rent 
time on the university super computer to 
compute the exact p-value. 
 
Simplicio: No, Socrates, computing has gotten 
to the point that I can compute the exact p-value 
instantaneously on my PC. 
 
Socrates: Is the exact test patented, so that you 
need to pay royalties to use it? 
 
Simplicio: No Socrates, that is not it either. 
 
Socrates: Why don’t you just tell me the reason? 
 
Simplicio: There is no additional cost in 
computing the exact p-value. 
 
Socrates: I see. But I am not sure that I like what 
I hear. You have no reason not to compute the 
exact p-value, yet choose not to do so even 
though your decision to use it or not to use it is 
based on how well an approximation 
approximates it. And you assess this closeness 
not by computing both quantities and simply 
comparing them but rather by using some vague 
notion of how well the assumptions of the 
approximation seem to hold, even though you 
readily admit that this has no implications for an 
upper bound on the difference between the two 
p-values. 
Then you count the times that you 
ostensibly do not need to compute the exact p-
value and offer this as further evidence of 
successes without the exact p-value, so more 
reason not to have to use it in the future. Tell 
me, Simplicio, can you offer a valid reason for 
this approach instead of simply computing both 
p-values and assessing the difference in this 
way? 
 
Simplicio: No, I am afraid that I cannot. 
 
Socrates: Would you agree that it would be 
better to dispense with this nonsense about 
testing the assumptions underlying the t-test, or 
similarly checking that expected cell counts 
exceed five for the chi-square test, and instead 
just compute both p-values, and note how close 
or far they are to each other? After all, how 
much power would you expect these tests to 
have to detect deviations from normality (or 
some other distribution) when the sample sizes 
are chosen not for this purpose but rather to 
detect a treatment effect? 
 
Simplicio: Yes, this would be better. 
 
Socrates: Let us anticipate your doing this in the 
future. You will then have an exact p-value as 
the gold standard, and you will have an 
approximation to it, the t-test p-value. How will 
you use these two to render a decision as to the 
suitability of the t-test? 
 
Simplicio: Socrates, as we already said, I would 
use the approximation only if it is close enough 
to the exact p-value. 
 
Socrates: When you go to the market for 
groceries, and the cashier totals the price of your 
selected merchandise, do you pay this amount, 
or some other amount that is close enough to this 
amount? I mean, one could obtain the dollar 
amount for the items in question, then toss two 
dice, and add (in cents) the value showing on the 
first die and subtract the value showing on the 
second die. The deviation would be no more 
than six cents either way. 
 
Simplicio: Of course, I pay the requested 
amount. 
 
Socrates: If you had a wrist watch with the 
approximate time, but also were able to see a 
clock with the exact time (which I could not 
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see), then what would you do if I, with no watch, 
were to ask you the time? 
 
Simplicio: I would imagine that I would tell you 
the time. 
 
Socrates: But how would you obtain the time? 
 
Simplicio: You just told me that there is a watch 
and a clock, so I can’t imagine having too much 
difficulty in telling the time. You seem to be 
belittling my intelligence, Socrates, but I assure 
you that even I can tell time. 
 
Socrates: I meant no offense, Simplicio, and 
rather meant to ask only which measure of time 
you would use. 
 
Simplicio: Because the clock has the exact time, 
I would use that one when it were available, as 
you said it would be in this case. I would use my 
watch only when I could not see the clock, or 
some other clock with a more precise measure of 
the time. 
 
Socrates: You would not check both the watch 
and the clock, and then decide to report the time 
on the watch if it were sufficiently close to the 
exact time on the clock? 
 
Simplicio: No, Socrates, this seems to me rather 
silly. If I can just check the exact time and tell 
you that, then why would I also check an 
approximation to a quantity I can observe? 
 
Socrates: If you can observe the exact p-value, 
then why would you go on to attempt to 
approximate it? How close must an 
approximation be before it is preferred to the 
very quantity it is attempting to approximate? 
 
Simplicio: I hear your point. 
 
Socrates: Is it not the case that decision analysts 
concern themselves with the value of perfect 
information? And do they not sometimes decide 
to exchange resources for additional 
information? It is unclear to me why someone 
would have perfect information, in the form of 
an exact value, and then choose to instead use 
imperfect information, in the form of an 
approximation. Have you considered the 
ramifications of this loss of information? 
 
Simplicio: It would not really matter too much if 
the two p-values are close, especially if they are 
both on the same side of alpha (0.05). 
 
Socrates: If the t-test p-value is 0.03 and, for the 
same data, the exact p-value is 0.04, then there is 
no harm in using the t-test? 
 
Simplicio: None that I can imagine. 
 
Socrates: Would there be any harm in using the 
exact p-value in this case? 
 
Simplicio: No, of course not! 
 
Socrates: Hence, we have one analysis that is 
always right, and another that is right or wrong 
depending on the extent to which it agrees with 
the first one. Because it is often close, we use 
the approximate one, is that it? 
 
Simplicio: At least when they are on the same 
side of alpha. 
 
Socrates: And alpha is always 0.05? 
 
Simplicio: Yes, this is an industry standard. 
 
Socrates: My dear Simplicio, at my age I suffer 
many ailments, including arthritis. Now suppose 
that a new medication comes along that can 
offer relief for my symptoms. How certain 
would I need to be that this new treatment is 
effective before I decide to take it? Surely this 
question cannot be answered in a vacuum, but 
rather requires careful consideration of the 
frequency and severity of side effects, would 
you agree? 
 
Simplicio: Most certainly. 
 
Socrates: Is it conceivable that, after considering 
the side effect profile, I would come up with a 
personal alpha level of 0.035? 
 
Simplicio: I cannot see why not. 
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Socrates: In such a case, I would take the 
medication if the primary efficacy p-value were 
0.03, but not if it were 0.04. Use of the t-test 
could change what should be 0.04 to 0.03. In 
other words, I would be misled into taking a 
medication that, were I to know all the facts, I 
would not take. I would be denied the ability to 
render an informed decision. 
 
Simplicio: I suppose so. 
 
Socrates: Are you familiar with dense sets, 
Simplicio? 
 
Simplicio: Are you calling me dense again 
Socrates? 
 
Socrates: No Simplicio, dense sets are a formal 
construct in mathematics. For example, the 
rational numbers are a dense subset of the real 
numbers, because between any two real 
numbers, no matter how close together, one can 
find a rational number. Is it not also the case that 
the set of potential personal alpha levels is a 
dense subset of the set of potential p-values? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Simplicio: Yes, I suppose that it is. 
 
Socrates: In that case, no matter how close the 
approximation is, somebody could have an alpha 
level that falls between the two p-values. In 
other words, the distortion in p-values created by 
the use of the approximation has consequences, 
not only abstractly, but also for real patients, the 
very patients who are relying on the researchers 
to provide unbiased information. 
 
Simplicio: I never looked at it that way. 
 
Socrates: Given the extent to which your 
research is funded by taxpayers, do you feel any 
obligation to deal with them honestly? 
 
Simplicio: Yes, Socrates, thank you for bringing 
these issues to my attention. From now on I will 
use nothing but exact p-values. 
